Introduction: Posthumanist Gender Theory—A Very Rough Account
Genealogy+Critique · 2023
DOI: 10.16995/gc.10863 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genealogy+Critique, 2023. Verfasst von Anna Babka und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This special collection, edited by Anna Babka, Hildegard Kernmayer, Julia Lingl, and Marietta Schmutz cuts across current positions and developments within the frame of what can be called posthuman gender theory, thereby questioning humanist-epistemological categories that continue to shape Western societies and their systems of knowledge production. Posthuman gender theory inscribes itself into the discussion about a "conditio posthumana." Thereby, the traditional essentialism of a biologically based two-gender system is questioned anew. At the same time, the "humanistic" idea of the superiority of man (as a male subject of domination) gives way to a post-anthropocentric conception of reality, according to which binary hierarchical oppositions such as man/animal or man/machine dissolve. This collection among others comprises transdisciplinary examinations of novels, comics, and other cultural or social phenomena and aims to participate in the ongoing development of posthumanist thinking in relation to gender and queer theory formation.
Zitieren
APA
Babka, A., Kernmayer, H., Lingl, J., & Schmutz, M. (2023). Introduction: Posthumanist Gender Theory—A Very Rough Account. Genealogy+Critique. https://doi.org/10.16995/gc.10863
Vancouver
Babka A, Kernmayer H, Lingl J, Schmutz M. Introduction: Posthumanist Gender Theory—A Very Rough Account. Genealogy+Critique. 2023. doi:10.16995/gc.10863
BibTeX
@article{Babka2023,
author = {Babka, Anna and Kernmayer, Hildegard and Lingl, Julia and Schmutz, Marietta},
title = {Introduction: Posthumanist Gender Theory—A Very Rough Account},
journal = {Genealogy+Critique},
year = {2023},
doi = {10.16995/gc.10863}
}
EUVIMED